Drawing for INVIZYNE

USPTO serial 90287671

INVIZYNE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
KEELEY, ALISON REBECCA
Law office
TMO LAW OFFICE 113

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with INVIZYNE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Thomas C. Lundin Jr.

Thomas C. Lundin Jr. FisherBroyles LLP111 Favre StWaveland, MS 39576UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003Fragrances; terpenes for use in essential oilsACTIVEMay 25, 2023
004Biofuels; fuels, biofuels and biodiesels based on energy-producing organic compounds, namely, terpenes, isoprenoids, alcohols, fatty acids, esters, alkanes, and alkenesACTIVEMay 25, 2023
005Pharmaceuticals, namely, alcohols, esters, alkaloids, polyketides, steroids, isoprenoids, and non-ribosomal peptides, for use the treatment of pain, neuropathic pain, cancer pain, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, multiple sclerosis, spinal cord injury, bladder disfunction, peripheral neuropathy, spasticity, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, post-traumatic stress disorder, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse, epilepsy, convulsions, seizures, Dravet syndrome, Lennox-Gastaut syndrome, intractable childhood epilepsy with generalized tonic-clonic seizures, generalized epilepsy with febrile seizures plus, Doose syndrome, chromosome disorders, and metabolic disorders; anti-inflammatories; analgesics; nutraceuticals for use as a dietary supplement; dietary and nutritional supplements; none of the foregoing containing CBD, cannabinoids or tryptaminesACTIVEMay 25, 2023
030Flavor enhancers for use in food and beverage productsACTIVEMay 25, 2023

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jul 2, 2026MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 2, 2026ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 18, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 18, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 18, 2026CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 16, 2024DOCKASSIGNED TO EXAMINER—
Sep 29, 2023DOCKASSIGNED TO EXAMINER—
Sep 5, 2023SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 31, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 24, 2023IUAFUSE AMENDMENT FILED—
Aug 24, 2023EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 23, 2023EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Aug 23, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 23, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 23, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 23, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 23, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 1, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 27, 2023EX2GSOU EXTENSION 2 GRANTED—
Feb 27, 2023EXT2SOU EXTENSION 2 FILED—
Feb 27, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 16, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 12, 2022EX1GSOU EXTENSION 1 GRANTED—
Aug 12, 2022EXT1SOU EXTENSION 1 FILED—
Aug 12, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 1, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 4, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 4, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 15, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 29, 2021ALIEASSIGNED TO LIE—
Nov 29, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 23, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Nov 23, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 23, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 23, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 25, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 24, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 24, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 27, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 27, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 27, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 26, 2021DOCKASSIGNED TO EXAMINER—
Dec 24, 2020MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Dec 23, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 2, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance